|Grant Affiliation:||Nussenzweig: Discovery & Characterization of bNAbs|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2013-12-20|
|Study Made Public:||2015-08-28|
Neutralization and Binding Data for 4 Germline Versions of bNAbs from HIV-Infected Patients
CAVD 435 is an immunogenicity study of broadly neutralizing antibodies to investigate the development of four germline versions of broadly neutralizing antibodies (bNAbs) that were previously identified in HIV-infected patients.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.